Source:http://linkedlifedata.com/resource/pubmed/id/12410643
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2002-11-4
|
pubmed:abstractText |
A multicentre study was performed in Sweden and the Netherlands, comparing effects of two prophylactic regimens in 128 patients with severe haemophilia, born 1970-90. 42 Swedish patients (high-dose prophylaxis), were compared with 86 Dutch patients (intermediate-dose prophylaxis). Patients were evaluated at the date of their last radiological score according to Pettersson. Annual clotting factor consumption and bleeding frequency were registered for a period of three years before evaluation. Patients in the high-dose group were younger at evaluation (median 15.2 vs. 17.9 years), started prophylaxis earlier (median 2 vs. 5 years), and used 2.19 times more clotting factor kg-1 year-1. Patients treated with high-dose prophylaxis had fewer joint bleeds (median 0.3 year-1 vs. 3.3 year-1) and the proportion of patients without arthropathy as measured by the Pettersson score was higher (69% vs. 32%), however, the age-adjusted difference in scores (median 0 points vs. 4 points) was small and at present not statistically significant. Clinical scores and quality of life were similar. These findings suggest that, compared with intermediate-dose prophylaxis, high-dose prophylaxis significantly increases treatment costs and reduces joint bleeds over a period of 3 years, but only slightly reduces arthropathy after 17 years of follow-up.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1351-8216
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
8
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
753-60
|
pubmed:dateRevised |
2009-10-21
|
pubmed:meshHeading |
pubmed-meshheading:12410643-Adolescent,
pubmed-meshheading:12410643-Adult,
pubmed-meshheading:12410643-Child,
pubmed-meshheading:12410643-Dose-Response Relationship, Drug,
pubmed-meshheading:12410643-Factor IX,
pubmed-meshheading:12410643-Factor VIII,
pubmed-meshheading:12410643-Follow-Up Studies,
pubmed-meshheading:12410643-Hemarthrosis,
pubmed-meshheading:12410643-Hemophilia A,
pubmed-meshheading:12410643-Hemophilia B,
pubmed-meshheading:12410643-Humans,
pubmed-meshheading:12410643-Male,
pubmed-meshheading:12410643-Quality of Life,
pubmed-meshheading:12410643-Treatment Outcome
|
pubmed:year |
2002
|
pubmed:articleTitle |
Prophylactic treatment for severe haemophilia: comparison of an intermediate-dose to a high-dose regimen.
|
pubmed:affiliation |
Department of Paediatrics, University Medical Center Utrecht, The Netherlands. k.fischer@azu.nl
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't,
Multicenter Study
|